Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Blood Cancer Journal|June 17, 2025
A phase 2 study of Daratumumab with Thalidomide and dexamethasone in relapsed and/or Refractory Myeloma (RRMM)Chandramouli Nagarajan, Wei-Ying Jen, Melissa Ooi, et al.
Blood Cancer Journal|February 13, 2021
Myeloma-specific superenhancers affect genes of biological and clinical relevance in myelomaYunlu Jia, Jianbiao Zhou, Tze King Tan, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 22, 2021
Admission ultrasonography as a predictive tool for thrombocytopenia and disease severity in dengue infectionCallum D Donaldson, Sanjay de Mel, Choong Shi Hui Clarice, et al.
Plos One|January 25, 2022
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survivalSanjay de Mel, Nurulhuda Mustafa, Viknesvaran Selvarajan, et al.
Blood Cancer Journal|August 13, 2021
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaShin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, et al.
Blood|August 1, 2018
Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosisPhaik Ju Teoh, Omer An, Tae-Hoon Chung, et al.
Annals of the Academy of Medicine, Singapore|June 26, 2024
AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and managementMelinda Tan, Yunxin Chen, Melissa Ooi, et al.
Cancer Letters|September 7, 2014
Combination of vaccine-strain measles and mumps virus synergistically kills a wide range of human hematological cancer cells: Special focus on acute myeloid leukemiaLi Feng Zhang, Darren Qian Cheng Tan, Anand D Jeyasekharan, et al.
Cancer Medicine|July 3, 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphomaEsther Hian Li Chan, Liang Piu Koh, Joanne Lee, et al.
Leukemia & Lymphoma|July 2, 2019
The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphomaMing Liang Oon, Michal M Hoppe, Shuangyi Fan, et al.
Pageof 8